Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vector-derived expression of recombinant rat interleukin-6

T A Braciak1, W Northemann, D K Chong

  • 1Department of Pathology, Molecular Virology and Immunology Program, McMaster University, Hamilton, Ontario, Canada.

Protein Expression and Purification
|May 1, 1996
PubMed
Summary

Researchers developed a novel method to produce biologically active rat interleukin-6 (IL-6) fusion protein in E. coli. This recombinant protein and its specific antiserum are valuable tools for studying IL-6 in inflammation and immunity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Musculovascular pattern in the myrtiform area: implications for cleft lip reconstruction.

International journal of oral and maxillofacial surgery·2026
Same author

Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulence.

Journal of thrombosis and haemostasis : JTH·2016
Same author

The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection.

Mucosal immunology·2015

Area of Science:

  • Molecular Biology
  • Immunology
  • Biochemistry

Background:

  • Interleukin-6 (IL-6) is a key cytokine regulating inflammation and immune responses.
  • Efficient production of recombinant IL-6 is crucial for its study and therapeutic applications.

Purpose of the Study:

  • To clone and express rat IL-6 as a fusion protein in Escherichia coli.
  • To develop a purification strategy for the recombinant protein.
  • To generate a specific antiserum against rat IL-6.

Main Methods:

  • Cloning of rat IL-6 cDNA into the pH6EX3 expression vector.
  • Expression in E. coli under tac promoter control, induced by IPTG.
  • One-step purification using nickel-chelating affinity chromatography.
  • Biological activity assays (hepatocyte stimulation, B9 hybridoma growth).

Related Experiment Videos

  • Antiserum generation using a recombinant adenovirus vector (Ad5E3rIL6).

    • Main Results:

    • Significant production of recombinant rat IL-6 fusion protein with an N-terminal histidine hexapeptide (HH).
    • Purified HH-IL-6 fusion protein demonstrated biological activity.
    • Antiserum raised against rat IL-6 neutralized both recombinant and natural IL-6 bioactivity.
    • The antiserum was effective in Western blot and immunohistochemistry.

    Conclusions:

    • A robust system for producing active recombinant rat IL-6 fusion protein was established.
    • The generated polyclonal antiserum is a potent tool for detecting and neutralizing rat IL-6.
    • These tools facilitate further research into IL-6's role in biological processes.